The latest news across UAEM regions.
UAEM North America Pressures U.S. FDA for Clinical Trial Transparency
Universities Allied for Essential Medicines (UAEM) North America, with assistance from Columbia Law School’s Science, Health and Information Clinic (SHIC), filed a citizen petition at the Food & Drug Administration (FDA) on February 27th to urge the agency to improve enforcement of clinical trial transparency. Transparency laws require public access to studies on drugs and medical devices, benefitting patients and researchers, but FDA has underenforced the law, keeping potentially life-saving data from the public.
It’s not the mission of universities to perpetuate inequity. Why do Emory and others do that?
As billions of people in the Global South continue to confront Covid-19 unprotected because they cannot access vaccines, a recent announcement regarding a new, potentially effective therapy offered a glimmer of hope.
Affordable, life-saving medicines for all: McGill adopts Global Access Licensing Principles for research conducted on campus
McGill University, in conjunction with Universities Allied for Essential Medicines (UAEM), has committed to increasing access to life-saving medicines by adopting Global Access Licensing Principles. McGill is the third Canadian university to adopt the principles, demonstrating a dedication to ensure that any research and university-developed technologies created on McGill’s campus with potential for further development into a drug, vaccine, or medical diagnostic are made affordable to all.
Upcoming events.
Join UAEM for global events, regional events, and more.
We’re a network of students all over the world fighting for an equitable research, development, and access to medicines ecosystem.
Find an event near you or online to learn more.